Total Funding
$32.4M
Employee Range
1-10
AnaCardio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for heart failure. By harnessing cutting-edge science, AnaCardio aims to create novel drugs that enhance patient outcomes and transform heart failure treatment, addressing a critical need in cardiovascular healthcare.
AnaCardio data powered by:
Share
AnaCardio data powered by:
AnaCardioOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
AnaCardioIndustry Rankings in
Healthtech
City Rank
Share
1st
In Solna
Top 17%out of 6 startups
National Rank
Share
39th
In Sweden
Top 16%out of 246 startups
Regional Rank
Share
1,072nd
In Western Europe
Top 24%out of 4549 startups
AnaCardioSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Solna
Top 34%out of 3 startups
National Rank
Share
13th
In Sweden
Top 14%out of 97 startups
Regional Rank
Share
452nd
In Western Europe
Top 27%out of 1726 startups
rankings by:
AnaCardioSB Rank Evolution
Not enough data points to display the chart.
AnaCardiostartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro